Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant

N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease involving many organ systems. Glomerulonephritis (GLN) is one of the major causes of morbidity and mortality in SLE. It has recently been demonstrated that adjuvants of vaccines could cause the so called ASIA syndrome. The study aimed to assess the effects of Complete Freund's Adjuvant (CFA) vs alum injections in NZB/NZWF1 mice. Mice (n=10 each group) were injected with a total volume of 200 μL of: CFA in PBS (group 1), alum in PBS (group 2), PBS (group 3) as controls, PTX3/CFA (group 4), PTX3/alum (group 5), 3 times, 3 weeks apart /given in each injection, three weeks apart from ten weeks of age. Urine samples were collected weekly to evaluate proteinuria. Blood samples were collected before every injection, at 21 weeks of age, and at death to evaluate levels of anti-PTX3 and anti-dsDNA. Proteinuria free survival and survival rates were analyzed by the Kaplan-Meier method using Mantel-Cox's test for comparisons. CFA-treated mice developed both anti-dsDNA antibodies and proteinuria earlier and at higher levels than alumtreated and PBS-injected mice, starting from 13 weeks of age. Proteinuria free survival rates (proteinuria ≥300 mg/dL) and survival rates were lower in CFA-treated mice than those treated with alum or injected with PBS (P

Original languageEnglish
Pages (from-to)380-387
Number of pages8
JournalReumatismo
Volume64
Issue number6
Publication statusPublished - 2012

Fingerprint

Freund's Adjuvant
Proteinuria
Vaccination
Research
Survival Rate
Systemic Lupus Erythematosus
Injections
Inbred NZB Mouse
Glomerulonephritis
Autoimmune Diseases
Anti-Idiotypic Antibodies
Vaccines
aluminum sulfate
Urine
Morbidity
Mortality

Keywords

  • Adjuvants
  • ASIA syndrome
  • Glomerulonephritis (GLN)
  • NZB/NZWF1 mice
  • Systemic lupus erythematosus (SLE)

ASJC Scopus subject areas

  • Rheumatology

Cite this

Bassi, N., Luisetto, R., Ghirardello, A., Gatto, M., Bottazzi, B., Shoenfeld, Y., ... Doria, A. (2012). Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant. Reumatismo, 64(6), 380-387.

Vaccination of mice for research purpose : Alum is as effective as and safer than complete Freund adjuvant. / Bassi, N.; Luisetto, R.; Ghirardello, A.; Gatto, M.; Bottazzi, B.; Shoenfeld, Y.; Punzi, L.; Doria, A.

In: Reumatismo, Vol. 64, No. 6, 2012, p. 380-387.

Research output: Contribution to journalArticle

Bassi, N, Luisetto, R, Ghirardello, A, Gatto, M, Bottazzi, B, Shoenfeld, Y, Punzi, L & Doria, A 2012, 'Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant', Reumatismo, vol. 64, no. 6, pp. 380-387.
Bassi N, Luisetto R, Ghirardello A, Gatto M, Bottazzi B, Shoenfeld Y et al. Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant. Reumatismo. 2012;64(6):380-387.
Bassi, N. ; Luisetto, R. ; Ghirardello, A. ; Gatto, M. ; Bottazzi, B. ; Shoenfeld, Y. ; Punzi, L. ; Doria, A. / Vaccination of mice for research purpose : Alum is as effective as and safer than complete Freund adjuvant. In: Reumatismo. 2012 ; Vol. 64, No. 6. pp. 380-387.
@article{5e65c6c3bdba41aeb47ddb66f560e3d5,
title = "Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant",
abstract = "Systemic lupus erythematosus (SLE) is an autoimmune disease involving many organ systems. Glomerulonephritis (GLN) is one of the major causes of morbidity and mortality in SLE. It has recently been demonstrated that adjuvants of vaccines could cause the so called ASIA syndrome. The study aimed to assess the effects of Complete Freund's Adjuvant (CFA) vs alum injections in NZB/NZWF1 mice. Mice (n=10 each group) were injected with a total volume of 200 μL of: CFA in PBS (group 1), alum in PBS (group 2), PBS (group 3) as controls, PTX3/CFA (group 4), PTX3/alum (group 5), 3 times, 3 weeks apart /given in each injection, three weeks apart from ten weeks of age. Urine samples were collected weekly to evaluate proteinuria. Blood samples were collected before every injection, at 21 weeks of age, and at death to evaluate levels of anti-PTX3 and anti-dsDNA. Proteinuria free survival and survival rates were analyzed by the Kaplan-Meier method using Mantel-Cox's test for comparisons. CFA-treated mice developed both anti-dsDNA antibodies and proteinuria earlier and at higher levels than alumtreated and PBS-injected mice, starting from 13 weeks of age. Proteinuria free survival rates (proteinuria ≥300 mg/dL) and survival rates were lower in CFA-treated mice than those treated with alum or injected with PBS (P",
keywords = "Adjuvants, ASIA syndrome, Glomerulonephritis (GLN), NZB/NZWF1 mice, Systemic lupus erythematosus (SLE)",
author = "N. Bassi and R. Luisetto and A. Ghirardello and M. Gatto and B. Bottazzi and Y. Shoenfeld and L. Punzi and A. Doria",
year = "2012",
language = "English",
volume = "64",
pages = "380--387",
journal = "Reumatismo",
issn = "0048-7449",
publisher = "PAGEPRESS PUBL",
number = "6",

}

TY - JOUR

T1 - Vaccination of mice for research purpose

T2 - Alum is as effective as and safer than complete Freund adjuvant

AU - Bassi, N.

AU - Luisetto, R.

AU - Ghirardello, A.

AU - Gatto, M.

AU - Bottazzi, B.

AU - Shoenfeld, Y.

AU - Punzi, L.

AU - Doria, A.

PY - 2012

Y1 - 2012

N2 - Systemic lupus erythematosus (SLE) is an autoimmune disease involving many organ systems. Glomerulonephritis (GLN) is one of the major causes of morbidity and mortality in SLE. It has recently been demonstrated that adjuvants of vaccines could cause the so called ASIA syndrome. The study aimed to assess the effects of Complete Freund's Adjuvant (CFA) vs alum injections in NZB/NZWF1 mice. Mice (n=10 each group) were injected with a total volume of 200 μL of: CFA in PBS (group 1), alum in PBS (group 2), PBS (group 3) as controls, PTX3/CFA (group 4), PTX3/alum (group 5), 3 times, 3 weeks apart /given in each injection, three weeks apart from ten weeks of age. Urine samples were collected weekly to evaluate proteinuria. Blood samples were collected before every injection, at 21 weeks of age, and at death to evaluate levels of anti-PTX3 and anti-dsDNA. Proteinuria free survival and survival rates were analyzed by the Kaplan-Meier method using Mantel-Cox's test for comparisons. CFA-treated mice developed both anti-dsDNA antibodies and proteinuria earlier and at higher levels than alumtreated and PBS-injected mice, starting from 13 weeks of age. Proteinuria free survival rates (proteinuria ≥300 mg/dL) and survival rates were lower in CFA-treated mice than those treated with alum or injected with PBS (P

AB - Systemic lupus erythematosus (SLE) is an autoimmune disease involving many organ systems. Glomerulonephritis (GLN) is one of the major causes of morbidity and mortality in SLE. It has recently been demonstrated that adjuvants of vaccines could cause the so called ASIA syndrome. The study aimed to assess the effects of Complete Freund's Adjuvant (CFA) vs alum injections in NZB/NZWF1 mice. Mice (n=10 each group) were injected with a total volume of 200 μL of: CFA in PBS (group 1), alum in PBS (group 2), PBS (group 3) as controls, PTX3/CFA (group 4), PTX3/alum (group 5), 3 times, 3 weeks apart /given in each injection, three weeks apart from ten weeks of age. Urine samples were collected weekly to evaluate proteinuria. Blood samples were collected before every injection, at 21 weeks of age, and at death to evaluate levels of anti-PTX3 and anti-dsDNA. Proteinuria free survival and survival rates were analyzed by the Kaplan-Meier method using Mantel-Cox's test for comparisons. CFA-treated mice developed both anti-dsDNA antibodies and proteinuria earlier and at higher levels than alumtreated and PBS-injected mice, starting from 13 weeks of age. Proteinuria free survival rates (proteinuria ≥300 mg/dL) and survival rates were lower in CFA-treated mice than those treated with alum or injected with PBS (P

KW - Adjuvants

KW - ASIA syndrome

KW - Glomerulonephritis (GLN)

KW - NZB/NZWF1 mice

KW - Systemic lupus erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=84872026447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872026447&partnerID=8YFLogxK

M3 - Article

C2 - 23285482

AN - SCOPUS:84872026447

VL - 64

SP - 380

EP - 387

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - 6

ER -